A new surgical technique is offering breast cancer survivors a chance to return to a quality of life they remember.

A Chinese phase 3 trial of Bristol Myers Squibb’s antibody-drug conjugate (ADC) has hit its dual primary survival endpoints, ...

About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to come back after the original treatment, significantly ...

EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening ...

Connie Lehman, Professor of radiology at Harvard Med School, CEO and founder of Clairity, Inc., a company pioneering ...

Medical professionals at Thomas Hospital successfully performed a new procedure to treat early-stage, low-risk breast tumors ...

A North Carolina woman says a preventive breast cancer vaccine being tested at the Cleveland Clinic is working for her.

Also known as metastatic breast cancer (mBC), Stage IV means the disease has spread to other parts of the body, and approximately 1 in 3 people with breast cancer develop mBC.³ In Lynn’s case, her ...

​Caris Life Sciences, Inc. (NASDAQ:CAI) is one of the Best All-Time Low Stocks to Invest In Now. On February 24, Caris Life ...